These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 7475895)

  • 1. Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig.
    Culpepper-Morgan JA; Holt PR; LaRoche D; Kreek MJ
    Life Sci; 1995; 56(14):1187-92. PubMed ID: 7475895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
    Capasso A; Sorrentino L; Pinto A
    Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally administered kappa as well as mu opiate agonists delay gastrointestinal transit time in the guinea pig.
    Culpepper-Morgan J; Kreek MJ; Holt PR; LaRoche D; Zhang J; O'Bryan L
    Life Sci; 1988; 42(21):2073-7. PubMed ID: 2838706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors.
    Morrone LA; Romanelli L; Amico MC; Valeri P
    Br J Pharmacol; 1993 May; 109(1):48-52. PubMed ID: 8388301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Fos-like immunoreactivity by opioids in guinea-pig brain.
    Bot G; Chahl LA
    Brain Res; 1996 Aug; 731(1-2):45-56. PubMed ID: 8883853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility.
    Agirregoitia E; Valdivia A; Carracedo A; Casis L; Gil J; Subiran N; Ochoa C; Irazusta J
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4969-75. PubMed ID: 16984994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
    Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
    Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mu and kappa opioid system interactions in the expression of acute opioid dependence in isolated guinea-pig ileum.
    Valeri P; Romanelli L; Morrone LA; Amico MC; Mattioli F
    Neuropharmacology; 1996 Mar; 35(3):377-84. PubMed ID: 8783213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay.
    Wettstein JG; Grouhel A
    Pharmacol Biochem Behav; 1996 Feb; 53(2):411-6. PubMed ID: 8808151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TENA, a selective kappa opioid receptor antagonist.
    Portoghese PS; Takemori AE
    Life Sci; 1985 Feb; 36(8):801-5. PubMed ID: 2983171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ; Członkowski A; Lipkowski A; Herz A
    J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive effects of morphine and U-50,488H on vaginal distension in the anesthetized rat.
    Friese N; Diop L; Lambert C; Rivière PJ; Dahl SG
    Life Sci; 1997; 61(16):1559-70. PubMed ID: 9353165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal by kappa-agonists of peritoneal irritation-induced ileus and visceral pain in rats.
    Friese N; Chevalier E; Angel F; Pascaud X; Junien JL; Dahl SG; Riviere PJ
    Life Sci; 1997; 60(9):625-34. PubMed ID: 9048965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of phosphoramidon-induced antinociception in mice by mu- but not kappa-opioid receptor blockers.
    Pruhs RJ; Peña RT; Quock RM
    Life Sci; 2007 Apr; 80(19):1816-20. PubMed ID: 17379253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mu-, delta- and kappa-agonists on isolated right atria of the rat.
    Micol JA; Laorden ML
    Neuropeptides; 1994 Jun; 26(6):365-70. PubMed ID: 7936123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro pharmacological characterization of naloxone benzoylhydrazone.
    Berzetei-Gurske IP; White A; Polgar W; DeCosta BR; Pasternak GW; Toll L
    Eur J Pharmacol; 1995 Apr; 277(2-3):257-63. PubMed ID: 7493617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.